Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 22, 2024

BUY
$15.61 - $23.34 $2,185 - $3,267
140 Added 35.09%
539 $8,000
Q2 2024

Jul 23, 2024

BUY
$11.83 - $24.05 $4,720 - $9,595
399 New
399 $6,000
Q2 2020

Aug 11, 2020

SELL
$57.2 - $74.41 $2,288 - $2,976
-40 Closed
0 $0
Q1 2020

May 06, 2020

BUY
$57.05 - $95.75 $2,282 - $3,830
40 New
40 $3,000

Others Institutions Holding NVCR

About NovoCure Ltd


  • Ticker NVCR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 104,950,000
  • Market Cap $2.01B
  • Description
  • NovoCure Limited, an oncology company, engages in the development, manufacture, and commercialization of tumor treating fields (TTFields) devices for the treatment of solid tumor cancers in the United States, Europe, the Middle East, Africa, Japan, and Greater China. Its TTFields devices include Optune for the treatment of glioblastoma; and Optu...
More about NVCR
Track This Portfolio

Track Macroview Investment Management LLC Portfolio

Follow Macroview Investment Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Macroview Investment Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Macroview Investment Management LLC with notifications on news.